Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

blank

 

Recent News and Articles on the Keywords: ovarian cancer + study highlights + risk  Related to the article below (Last Update: 5/5/2008)

Clavis Pharma's First Quarter Results
PharmaLive.com (press release), PA - Apr 24, 2008
On 13 March 2008, the Company announced the initiation of a new clinical Phase II study with ELACYT in ovarian cancer. The study is designed to show ...OSL:CLAVIS
GlaxoSmithKline Reports Further Progress of Oncology Portfolio
Earthtimes, UK - Apr 22, 2008
Highlights of the GSK Oncology data to be presented at ASCO include: Breast Cancer -- A randomized study of lapatinib (TYKERB) in combination with ...GSK
SuperGen Reports 2008 First Quarter Financial Results
Earthtimes (press release), UK - Apr 28, 2008
Additionally, S-110 restored sensitivity to cisplatin in the ovarian cancer model. Reduced toxicity was observed along with an increased half-life compared ...SUPG
Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Canada NewsWire (press release), Canada - Apr 30, 2008
These cancer indications were selected after comprehensive preclinical studies carried out by the NCI indicated the reovirus can kill ovarian cancer cells. ...ONCY
Landslide victim wants neighbor,county to pay
Longview Daily News, WA - Apr 6, 2008
The hill crashed down less than a month after Chuck Anderson's wife, Deborah, died of ovarian cancer. Wade Anderson said the mud and trees buried a flower ...

In order to show you the most relevant results, we have omitted some entries very similar to the 5 already displayed.
If you like, you can repeat the search with the omitted results included.

Source: Google News

Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer -
A Goldhirsch, JH Glick, RD Gelber, AS Coates, HJ … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org
... et al: Meeting highlights: International consensus ... Text]; International Breast Cancer
Study Group: Randomized controlled trial of ovarian function suppression ...

Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations … -
G Ursin - Cancer Research, 1997 - AACR
... Coates, and HJ Senn Meeting Highlights: International Consensus ... MC Yu Family History
and Risk of Renal ... and the National Israel Ovarian Cancer Study Group Parity ...

Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer -
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B … - Journal of Clinical Oncology, 2003 - jco.ascopubs.org
... positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. ...
2002 [Abstract/Free Full Text]; Davidson NE: Ovarian ablation as ...

Recent developments in ovarian cancer screening. -
U Menon, IJ Jacobs - Current Opinion in Obstetrics and Gynecology, 2000 - co-obgyn.com
... The study highlights the need for researchers to be aware of the limitations
of ovarian cancer case ascertainment via cancer registers alone ...

Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer -
A Goldhirsch, JH Glick, RD Gelber, AS Coates, B … - Annals of Oncology, 2005 - pt.wkhealth.com
... in blood lipids) require further study [71]. ... with ER-positive breast cancer should
include ... endocrine responsive disease, combined ovarian function suppression ...

Very High Risk of Cancer in Familial Peutz-Jeghers Syndrome -
FM Giardiello*,?, JD Brensinger*, AC Tersmette?, SN … - Gastroenterology, 2000 - Elsevier
... cancer (36%), stomach (29%), and ovarian (21%) cancer. ... for a more extensive cohort
study using data ... Peutz?Jeghers registries to better estimate cancer risk. ...

… for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study -
PG Rose, JA Blessing, AR Mayer, HD Homesley - Journal of Clinical Oncology, 1998 - jco.ascopubs.org
... and Tubal Carcinoma: A Gynecologic Oncology Group Study J. Clin ... Home page, The
Oncologist Home page M. Seiden Highlights in Ovarian Cancer Oncologist, August 1 ...

… support for recording and interpreting family histories of breast and ovarian cancer in primary care … -
J Emery, R Walton, A Coulson, D Glasspool, S … - BMJ: British Medical Journal, 1999 - pubmedcentral.nih.gov
... family histories of breast and ovarian cancer in primary ... assessment of genetic risk
of cancer in primary ... This study highlights the need for careful evaluation ...

Risk Communication in Genetic Testing for Cancer Susceptibility -
RT Croyle, C Lerman - jncimono, 1999 - jncimono.oxfordjournals.org
... Unlike breast-ovarian cancer, a positive genetic test result for ... In this study,
individuals who had high ... Thus, their cancer risk status remained uncertain, and ...

… up of cohort of 46 000 women from Royal College of General Practitioners? oral contraception study -
V Beral, C Hermon, C Kay, P Hannaford, S Darby, G … - BMJ: British Medical Journal, 1999 - pubmedcentral.nih.gov
... For ovarian cancer there was a weak suggestion that the ... use, which included data
from this study, showed that the incidence of breast cancer was slightly ...

Source: Google Scholar

Studies Highlight Strategies to Reduce Ovarian, Breast Cancer Risk

New research confirms that removing the ovaries can drastically reduce the risk of ovarian cancer in women who have certain genetic mutations. And all women can cut their risk of breast cancer by losing weight after menopause.

In the first study, a team of international researchers followed a group of women with mutations in the BRCA1 or BRCA2 genes for an average of 3.5 years. Women who have these genetic mutations are known to have a much higher rate of breast and ovarian cancers. Some of the women had their ovaries removed as a preventive measure to reduce their risk of cancer, while others did not. The procedure is called oophorectomy. The researchers found that removing the ovaries reduced the risk of ovarian cancer by 80 percent.

"The risk of ovarian cancer was reduced by 80 percent, but seven women still got cancer after their ovaries were removed, so there's still a 4 percent chance of having cancer after oophorectomy," said one of the study's authors, Dr. Steven Narod, a Canada Research Chair in Breast Cancer and a professor of public health sciences at the Centre for Research in Women's Health in Toronto.

Narod said the researchers had hoped to see an even greater reduction in risk, because when they studied women with these genetic mutations after prophylactic removal of their breasts, none of the women developed breast cancer.

In the second study, researchers gathered information on weight status throughout the lives of more than 87,000 postmenopausal women in the Nurses' Health Study. The researchers found that weight gain, especially after menopause, can increase the risk of breast cancer, but that post-menopausal weight loss can reduce the risk of breast cancer.

"The good news is that it's never too late to lose weight to reduce your risk of breast cancer, but the best thing is to avoid weight gain in the first place," said the study's lead author, Heather Eliassen, an instructor in medicine at Brigham and Women's Hospital and the Harvard School of Medicine and Public Health, in Boston.

Results of these studies are in the July 12 issue of the Journal of the American Medical Association.

Narod's study included 1,828 women from Canada, the United States, Europe and Israel known to carry either the BRCA1 or BRCA2 mutation. Before the study began, 555 of the women had their ovaries and fallopian tubes removed. Another 490 women had them removed during the study period, while 783 did not have the procedure.

Thirty-two cases of ovarian cancer were found in the women who still had their ovaries intact. Just seven of the women who underwent the procedure were diagnosed with what appeared to be ovarian cancer, Narod said.

The cancers that developed in the women who'd had their ovaries removed occurred in the peritoneum, the lining of the abdomen. Narod said this tissue is similar to ovarian tissue. Unlike the ovaries, the peritoneum cannot be removed.

The researchers estimated the cumulative 20-year risk of ovarian cancer for women who have had their ovaries removed at about 4 percent. Without the procedure, about 40 percent of women with the BRCA1 mutation can expect to develop ovarian cancer. For the average woman, the rate is about 1.4 percent over a lifetime, Narod said.

Dr. Jay Brooks, chairman of hematology/oncology at the Ochsner Clinic Health System in Baton Rouge, La., said, "If you have a BRCA mutation, and you have not had your ovaries and uterus removed, they need to be removed once you have completed childbearing. It's the single greatest thing to do to reduce ovarian-cancer risk, and it reduces the risk of breast cancer, too."

From the large group of women involved in the Nurses' Health Study, Eliassen and her colleagues discovered 4,393 cases of invasive breast cancer. When they looked at the effect of weight changes that had occurred since these women were 18 years old, the researchers saw a definite link between weight and breast-cancer risk.

In fact, the researchers concluded that 15 percent of these breast-cancer cases might be attributable to weight gains of just 2 kilograms or more since age 18. Two kilograms is about four-and-a-half pounds.

Women who gained 55 pounds or more had almost a 50 percent higher risk of developing breast cancer than women who had maintained their weight. Those who gained about 22 pounds since the age of 18 had about a 20 percent higher risk of breast cancer.

The good news from this study, however, was that women who lost 22 pounds or more after menopause and kept the weight off reduced their risk of breast cancer by nearly 60 percent.

Eliassen said that after menopause, the hormone estrogen is made primarily in fat tissue, and the more fat you have, the more estrogen your body will produce. This can increase breast-cancer risk, because many breast cancers are fueled by estrogen.

More information

To learn more about risk factors for cancer, visit the National Cancer Institute.

Drug Abuse Could Be in the Genes

Your genes could be key to how easily you could take up illicit drugs, a new study finds.

The study looked at 1,400 pairs of young adult twins in Norway, which has a much lower rate of drug use than many other countries.

"Prior twin studies of illicit drug use and abuse have all been conducted in Anglophonic countries, specifically the United States and Australia, with high levels of such use," study lead author Dr. Kenneth S. Kendler, professor of psychiatry and human genetics at Virginia Commonwealth University School of Medicine in Richmond, said in a prepared statement.

"This is the first study of a non-English speaking country with much lower rates of drug use -- yet results are similar -- drug use and abuse or dependence is quite heritable," Kendler said.

The Norwegian twins were interviewed and assessed for their lifetime use of illicit drugs, including marijuana, cocaine, opiates, psychedelics, and stimulants. For this study, significant lifetime use of illicit drugs was defined as 10 or more instances of use.

The researchers examined both genetic and environmental factors that might influence illicit drug use and concluded that genetics can play an important role.

The study was published in the July issue of the journal Psychological Medicine.

"In addition to prior findings, the results of this investigation indicate that genetic factors are likely to be important risk factors for psychoactive drug use and misuse in many parts of the world," Kendler said.

He noted that the findings of this new study contradict previous theories suggesting that genetic factors may have less of an impact in societies where illicit drugs are not widely available.

More information

The U.S. National Institute on Drug Abuse has more about drug abuse and addiction.

 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.